ask="7.75"
ask_size="100"
average_daily_volume="967174"
bid="5.01"
bid_size="100"
book_value="0.05"
change="-0.24"
change_from_200_day_moving_average="0.62"
change_from_50_day_moving_average="-0.29"
change_from_52_week_high="-1.70"
change_From_52_week_low="4.05"
change_in_percent="-3.93%"
close="5.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="46578000"
high="6.10"
high_52_weeks="7.56"
last_trade_date="2/22/2017"
last_trade_price="5.86"
last_trade_size="56327"
last_trade_time="4:00pm"
low="5.86"
low_52_weeks="1.81"
market_capitalization="432.22M"
moving_average_200_day="5.24"
moving_average_50_day="6.15"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.10"
open="6.10"
pe_ratio="N/A"
peg_ratio="-0.36"
percent_change_from_200_day_moving_average="+11.80%"
percent_change_from_50_day_moving_average="-4.76%"
percent_change_from_52_week_high="-22.49%"
percent_change_from_52_week_low="+223.76%"
previous_close="6.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="112.96"
price_per_sales="20.48"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="886376"
weeks_range_52="1.81 - 7.56"
